TG THERAPEUTICS, INC. (TGTX) Net income 2016–2025
TG THERAPEUTICS, INC. (TGTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$447.2MFY2025 · since FY2016: -$78.3M → $447.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $447.2M | +1812.4% |
| FY2024 | $23.4M | +84.5% |
| FY2023 | $12.7M | +105.7% |
| FY2022 | -$223.8M | +35.7% |
| FY2021 | -$348.1M | -24.6% |
| FY2020 | -$279.4M | -61.6% |
| FY2019 | -$172.9M | +0.4% |
| FY2018 | -$173.5M | -46.4% |
| FY2017 | -$118.5M | -51.4% |
| FY2016 | -$78.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TGTX financial trends
TGTX RevenueTGTX Net marginTGTX Gross profitTGTX Gross marginTGTX Operating incomeTGTX Operating marginTGTX Operating cash flowTGTX Free cash flowTGTX Capital expendituresTGTX Return on equityTGTX Stock buybacksTGTX Dividends paidTGTX Total assetsTGTX Total liabilitiesTGTX Shareholders’ equityTGTX overview →